RELIQ HEALTH TECHNOLOGIES INC. ("RHT")
BULLETIN TYPE: Private Placement-Non-Brokered, Convertible Debenture/s
BULLETIN DATE: April 21, 2017
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced April 20, 2017:
Convertible Debenture $762,304.97
Conversion Price: Convertible into units consisting of one common share and one half of one common share purchase warrant at $0.13 of principal outstanding.
Maturity date: 3 years from closing
Warrants Each warrant will have a term of three years from the date of issuance of the notes and entitle the holder to purchase one common share. The warrants are exercisable at the price of $0.20.
Interest rate: 8% per annum
Number of Placees: 12 Placees
Insider / Pro Group Participation:
Insider=Y /
Name ProGroup=P Debenture
Aman Thindal Y $100,000
Finder's Fee: Raymond James Ltd. receives $7,280 and 350,000 non-transferable warrants, each exercisable for one share at a price of $0.20 for a one year period.
PI Financial Corp. receives $8,000.
Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company must issue a news release announcing the closing of the private placement and setting out the expiry dates of the hold period(s). The Company must also issue a news release if the private placement does not close promptly. [Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.]
________________________________________
|
|
